Straits Research released its highly anticipated report, ” Global Respiratory Care Devices Market Size & Outlook, 2026-2034.” According to the study, the global market size is valued at USD 26.40 billion in 2025 and is projected to expand to USD 45.13 billion by 2034, registering a compound annual growth rate (CAGR) of 6.18%.

Market Dynamics

The market growth is primarily attributed to the rising prevalence of chronic respiratory diseases as well as advancements in respiratory care technologies, including smart and connected devices. In addition, the rise in the aging population has significantly contributed to the demand for respiratory care devices, as the prevalence of chronic respiratory conditions also increases with age. This growing patient population creates a higher need for therapeutic, monitoring, and diagnostic devices across both home and hospital settings, hence contributing to the growth of respiratory care solutions worldwide. However, the high cost of advanced respiratory equipment and limited reimbursement policies, particularly in developing regions, hinder the market growth. Moreover, the integration of telehealth and remote monitoring presents a significant opportunity for the respiratory care devices market. For example, in March 2025, a study published in the International Journal of Scientific Research and Engineering Development describes an IoT-based system for real-time detection of sleep apnea. This system utilizes IoT technology to track vital sleep patterns, including snoring and irregular breathing, which are indicative of sleep apnea. Such innovations create opportunities for expanding home based respiratory care and enhancing patient convenience and outcomes.

Market Highlights

• Product: The Therapeutic Devices segment dominated the market in 2025, with a revenue share of 59.42%.
• Application: The Sleep Apnea segment is estimated to grow at the fastest pace with a CAGR (8.12%) during the forecast period.
• End-User: The Hospitals segment dominated the market in 2025 with a revenue share of 35.23%, owing to the high volume of patients requiring critical respiratory care and the availability of advanced respiratory care infrastructure and trained healthcare professionals.
• Regional Insights: North America dominated the market with a 45.72% share, fuelled by the growing awareness of respiratory care solutions.